HIKALNSEHikal Limited· PharmaceuticalsMediumNeutral
Announced Tue, 23 Sept · 20:14 IST

Outcome of 37th Annual General Meeting

Board & Shareholder Meetings View source PDF

HIKAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Hikal Limited held its 37th Annual General Meeting on September 23, 2025, where shareholders approved several key items. These included the audited standalone and consolidated financial statements for the financial year ending 31 March 2025. Members also confirmed a total dividend of ₹1.40 per equity share (face value ₹2) for FY24-25, comprising a ₹0.60 interim dividend already paid and a ₹0.80 final dividend. Mr. Amit Kalyani (DIN: 00089430) was re-appointed as a Non-Executive, Non-Independent Director. Additionally, M/s Dhrumil M Shah & Co. LLP was appointed as Secretarial Auditor for a five-year term (FY2025-26 to FY2029-30), and the remuneration of M/s V.J. Talati & Co. as Cost Auditors for FY2025-26 was ratified.

Likely market impact

The ₹1.40 per share total dividend (₹0.80 final dividend on top of the ₹0.60 interim) provides a steady income return for shareholders. The approvals are largely routine governance matters with no negative surprises, signalling continued operational stability and regulatory compliance.